LifeStance Health Group, Inc. (NASDAQ:LFST) Stock Position Raised by Wellington Management Group LLP

Wellington Management Group LLP lifted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 9.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,276,237 shares of the company's stock after acquiring an additional 445,796 shares during the period. Wellington Management Group LLP owned about 1.38% of LifeStance Health Group worth $38,886,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Blue Trust Inc. raised its holdings in shares of LifeStance Health Group by 124.4% during the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock worth $27,000 after purchasing an additional 2,122 shares during the period. Townsquare Capital LLC acquired a new stake in LifeStance Health Group during the third quarter worth about $73,000. R Squared Ltd bought a new position in LifeStance Health Group in the fourth quarter worth about $80,000. Cibc World Markets Corp bought a new position in LifeStance Health Group in the fourth quarter worth about $96,000. Finally, Handelsbanken Fonder AB acquired a new position in LifeStance Health Group in the fourth quarter valued at approximately $128,000. 85.50% of the stock is currently owned by institutional investors.

Insider Activity at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the transaction, the insider now directly owns 339,810 shares in the company, valued at $2,344,689. This trade represents a 5.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 6.60% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

LFST has been the topic of several recent research reports. The Goldman Sachs Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price target on the stock in a report on Monday, December 16th. Canaccord Genuity Group assumed coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 target price on the stock. KeyCorp began coverage on shares of LifeStance Health Group in a report on Tuesday. They set an "overweight" rating and a $9.00 price target for the company. Finally, William Blair reaffirmed an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $8.58.

LifeStance Health Group Stock Performance

LFST stock traded up $0.07 during trading on Friday, reaching $6.84. 1,837,012 shares of the company's stock were exchanged, compared to its average volume of 1,608,433. LifeStance Health Group, Inc. has a 1-year low of $4.64 and a 1-year high of $8.61. The firm has a market cap of $2.63 billion, a PE ratio of -26.31 and a beta of 1.30. The company's fifty day moving average price is $7.28 and its 200-day moving average price is $7.33. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.